Atrial fibrillation is the most frequent sustained cardiac arrhythmia, and represents a frequent cause of any ischemic stroke, as well as the leading cause of thromboembolic stroke. Correct approaches of oral anticoagulation are crucial to prevent atrial fibrillation-related thromboembolic events. This book provides practical indications on the strategies of oral anticoagulation for all settings of atrial fibrillation patients. The book is timely, as in particular it delivers information and suggestions on the use of direct oral anticoagulants in a variety of “difficult” clinical contexts derived from research data and their clinical use in the last 15 years. Newest antithrombotic treatments and contemporary non-pharmacological approaches to prevent thrombotic complications in patients with atrial fibrillation are also addressed in the book.
Indice testuale
Coagulative patterns in atrial fibrillation
Martina Berteotti, Domenico Prisco, Rossella Marcucci
Thromboembolic risk stratification in patients with atrial fibrillation
Felice Gragnano, Vincenzo De Sio, Antonio Capolongo, Fabrizia Terracciano, Paolo Calabrò
Antithrombotic agents to prevent thromboembolism in atrial fibrillation - Antiplatelet therapy
Marco Palmieri, Stefano Benenati, Italo Porto
Antithrombotic agents to prevent thromboembolism in atrial fibrillation - Vitamin K antagonist anticoagulants
Giulia Renda, Francesca Ciliberti
Antithrombotic agents to prevent thromboembolism in atrial fibrillation - Non-vitamin K antagonist oral anticoagulants or direct oral anticoagulants
Paolo Ciacci, Ilaria Cavallari
Monitoring of oral anticoagulation in atrial fibrillation
Corrado Lodigiani, Luca Librè
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with CHA2DS2-VASc score 0/CHA2DS2-VA score 0
Domenico D’Amario, Giuseppe Patti
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with CHA2DS2-VASc score 1/CHA2DS2-VA score 1
Gabriele Dell’Era, Giuseppe Patti
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients undergoing cardioversion
Vincenzo Russo, Michele Iavarone, Antonello D’Andrea
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with concomitant coronary artery disease
Andrea Rubboli, Matteo Lisi
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients undergoing elective surgery
Giuseppe Patti, Chiara Ghiglieno
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with bleeding, trauma or urgent, unplanned surgery
Vittorio Pengo
Oral anticoagulation in specific settings of patients with atrial fibrillation - Elderly/very elderly and fragile patients
Roberto Presta, Enrico Brunetti, Mario Bo
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients at the extremes of body weight
Federica De Vecchi, Giuseppe Patti
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with chronic kidney disease
Carmen A. Spaccarotella, Andrea Mariani, Giovanni Esposito, Ciro Indolfi
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with cancer
Paola Gargiulo, Ermanno Nardi, Stefania Paolillo, Sara Fontanarosa, Pasquale Perrone Filardi
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with different ethnicities
Rossella De Maria, Bianca Pellizzeri, Clelia Licata, Luca Lombardo, Marco Frazzetto, Bruno Francaviglia, Piera Capranzano
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients in pregnancy
Marco G. Mennuni, Giuseppe Patti
Oral anticoagulation in specific settings of patients with atrial fibrillation - Re-introduction of anticoagulation in patients after a major bleeding event
Giorgio Quadri, Giuseppe Musumeci, Roberta Rossini
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients receiving ablation
Massimo Grimaldi, Antonio Di Monaco
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients undergoing transcatheter aortic valve replacement
Pierluigi Merella, Gavino Casu
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with secondary forms of atrial fibrillation
Letizia Riva, Giuseppe Di Pasquale
Oral anticoagulation in specific settings of patients with atrial fibrillation - First episode of post-operative atrial fibrillation
Giuseppe Lanzillo, Rossana Totaro, Sergio Leonardi
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with valvular heart disease
Greca Zanda, Ferdinando Varbella, Leonardo Grisafi
Oral anticoagulation in atrial fibrillation: a look to the future
Antonella Scala, Gianluca Campo, Giuseppe Patti
Alternative treatments to oral anticoagulation for preventing thromboembolism in atrial fibrillation
Antonio Rapacciuolo, Alfonsomaria Salucci
Martina Berteotti, Domenico Prisco, Rossella Marcucci
Thromboembolic risk stratification in patients with atrial fibrillation
Felice Gragnano, Vincenzo De Sio, Antonio Capolongo, Fabrizia Terracciano, Paolo Calabrò
Antithrombotic agents to prevent thromboembolism in atrial fibrillation - Antiplatelet therapy
Marco Palmieri, Stefano Benenati, Italo Porto
Antithrombotic agents to prevent thromboembolism in atrial fibrillation - Vitamin K antagonist anticoagulants
Giulia Renda, Francesca Ciliberti
Antithrombotic agents to prevent thromboembolism in atrial fibrillation - Non-vitamin K antagonist oral anticoagulants or direct oral anticoagulants
Paolo Ciacci, Ilaria Cavallari
Monitoring of oral anticoagulation in atrial fibrillation
Corrado Lodigiani, Luca Librè
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with CHA2DS2-VASc score 0/CHA2DS2-VA score 0
Domenico D’Amario, Giuseppe Patti
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with CHA2DS2-VASc score 1/CHA2DS2-VA score 1
Gabriele Dell’Era, Giuseppe Patti
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients undergoing cardioversion
Vincenzo Russo, Michele Iavarone, Antonello D’Andrea
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with concomitant coronary artery disease
Andrea Rubboli, Matteo Lisi
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients undergoing elective surgery
Giuseppe Patti, Chiara Ghiglieno
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with bleeding, trauma or urgent, unplanned surgery
Vittorio Pengo
Oral anticoagulation in specific settings of patients with atrial fibrillation - Elderly/very elderly and fragile patients
Roberto Presta, Enrico Brunetti, Mario Bo
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients at the extremes of body weight
Federica De Vecchi, Giuseppe Patti
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with chronic kidney disease
Carmen A. Spaccarotella, Andrea Mariani, Giovanni Esposito, Ciro Indolfi
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with cancer
Paola Gargiulo, Ermanno Nardi, Stefania Paolillo, Sara Fontanarosa, Pasquale Perrone Filardi
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with different ethnicities
Rossella De Maria, Bianca Pellizzeri, Clelia Licata, Luca Lombardo, Marco Frazzetto, Bruno Francaviglia, Piera Capranzano
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients in pregnancy
Marco G. Mennuni, Giuseppe Patti
Oral anticoagulation in specific settings of patients with atrial fibrillation - Re-introduction of anticoagulation in patients after a major bleeding event
Giorgio Quadri, Giuseppe Musumeci, Roberta Rossini
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients receiving ablation
Massimo Grimaldi, Antonio Di Monaco
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients undergoing transcatheter aortic valve replacement
Pierluigi Merella, Gavino Casu
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with secondary forms of atrial fibrillation
Letizia Riva, Giuseppe Di Pasquale
Oral anticoagulation in specific settings of patients with atrial fibrillation - First episode of post-operative atrial fibrillation
Giuseppe Lanzillo, Rossana Totaro, Sergio Leonardi
Oral anticoagulation in specific settings of patients with atrial fibrillation - Patients with valvular heart disease
Greca Zanda, Ferdinando Varbella, Leonardo Grisafi
Oral anticoagulation in atrial fibrillation: a look to the future
Antonella Scala, Gianluca Campo, Giuseppe Patti
Alternative treatments to oral anticoagulation for preventing thromboembolism in atrial fibrillation
Antonio Rapacciuolo, Alfonsomaria Salucci
